Many people have started to take an interest in this lately. Mounjaro Weight Loss Pen It's becoming more popular because it's being talked about as another trending weight control aid and has received positive feedback.Approved by the Thai Food and Drug Administration (FDA). Many people wonder if it really helps with weight loss? Is it dangerous? The key feature of Mounjaro is that it helps control appetite and manage weight under proper supervision. Therefore, it has become an option for those who have tried to lose weight on their own but haven't seen much results. This article will introduce you to... What is Mounjaro? How does it help with weight loss? Who is it suitable for? And what should you know before using it? A simple explanation before making a decision.
Main content
- Mounjaro slimming pen Mounjaro is an injectable medication belonging to the Dual GIP and GLP-1 receptor agonist group. It's a novel injectable drug for weight loss and blood sugar control. Mounjaro helps control hunger, improves metabolism, and regulates overall metabolic processes.
- The Mounjaro weight-loss pen uses Tirzepatide, a dual agonist medication. This works by mimicking the action of two natural hormones: GLP-1 (Glucagon-like Peptide-1) and GIP (Glucose-dependent Insulinotropic Polypeptide).
- Mounjaro comes in 6 sizes.These include 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg.
- People who should use Mounjaro for weight loss. For example, individuals with a Body Mass Index (BMI) ≥ 30 or ≥ 27, and those with chronic diseases such as diabetes, hypertension, and high cholesterol. Individuals who should not use Mounjaro for weight loss include those under 18 years of age, individuals with thyroid cancer, or those with a family history of medullary thyroid cancer.
- Possible side effects During the first 1-2 weeks of starting the weight-loss injection, common symptoms include nausea, vomiting, diarrhea, constipation, abdominal pain, and bloating.
What is Mounjaro weight-loss pen?
Mounjaro, or its trade name "Tirzepatide," is an injectable medication in the dual GIP and GLP-1 receptor agonist group. It's a novel injectable drug used for weight loss and blood sugar control. Mounjaro is manufactured by Eli Lilly & Co. of the United States.
Mounjaro has properties that help control hunger, making you feel full longer without having to fast, improving your metabolism, and helping to control...Metabolism And after the injection, weight loss can be greater than 15% – 20% or possibly more, depending on several factors such as the amount of drug used or the individual's body. It is also approved by the US FDA for the treatment of type 2 diabetes and for weight management.
In Thailand, as of 2025-2026, the Monjaro weight-loss pen was registered as a weight-loss and diet-control medication with the Food and Drug Administration (FDA), and imported and distributed through Zuellig Pharma.
How the Mounjaro slimming pen works.
The Mounjaro weight loss pen uses Tirzepatide, a dual agonist that mimics the action of two natural hormones: GLP-1 (Glucagon-like Peptide-1) and GIP (Glucose-dependent Insulinotropic Polypeptide), to reduce appetite and decrease energy expenditure.
How the Mounjaro slimming pen works.
GLP-1 (Glucagon-like Peptide-1) It functions to slow down the movement of food from the stomach, resulting in a longer and faster feeling of fullness. It also sends signals to the brain to reduce hunger and helps control blood sugar levels.
GIP (Glucose-dependent Insulinotropic Polypeptide) It functions to stimulate insulin secretion when blood sugar levels are high, and improves the efficiency of sugar and fat metabolism. It also helps reduce nausea that is often caused by GLP-1 stimulation alone.
After receiving a weight-loss injection, the results include eating less, feeling full faster, and the body managing blood sugar and fat levels more efficiently.
How many sizes of Mounjaro are there?
Mounjaro is designed with a gradual dosage adjustment to allow the body to gradually adapt and reduce gastrointestinal side effects. Mounjaro is available in 6 strengths, as shown in the table below.
| Dosage (of medicine) | Purpose and use |
| 2.5 mg | The initial dose, to allow the body to become accustomed to the medication, will be injected once a week for 4 weeks. |
| 5 mg | If the body tolerates the 2.5 mg dose well, the doctor will begin adjusting the dosage to 5 mg to start treatment more aggressively. |
| 7.5 mg | Doctors will begin adjusting the dosage to 7.5 mg if blood sugar levels or weight targets are still not met. |
| 10 mg | For cases where better treatment outcomes are desired. |
| 12.5 mg | For individuals who desire stricter control and whose bodies can tolerate the side effects. |
| 15 mg | The maximum dose, as prescribed by your doctor, is 15 mg, once your body has tolerated the side effects of the 12.5 mg dose well. |
Who “should” and “should not” use Mounjaro for weight loss.
People who should use Mounjaro for weight loss.
- Individuals with a Body Mass Index (BMI) ≥ 30 or ≥ 27 and chronic diseases such as diabetes, hypertension, and high cholesterol, etc.
- Individuals who are resistant to weight loss despite dietary control or exercise, and find it difficult to lose weight.
- Individuals who have localized fat accumulation, such as in the abdomen, upper arms, and legs.
- Individuals who experience the yo-yo effect after losing weight using other methods.
- Individuals who want to lose weight safely without harming their health.
- Individuals with type 2 diabetes who need to control their blood sugar and lose weight at the same time.
- Individuals who have been medically assessed and determined to have no contraindications to the use of the medication.
- The person wants to lose weight without undergoing gastric surgery or liposuction.
- Individuals with physical limitations in terms of exercise.
People who should not use Mounjaro for weight loss.
- Persons under 18 years of age
- Individuals with medullary thyroid cancer, or a family history of thyroid cancer.
- Individuals with Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2)
- Individuals with type 1 diabetes or diabetic ketoacidosis (DKA).
- Individuals with a history of and currently diagnosed pancreatitis.
- People with kidney disease or kidney failure.
- Individuals with diabetic retinopathy.
- Individuals with a history of allergy to Tirzepatide or any of its components (hypersensitivity).
- Individuals who want to lose weight quickly without changing their lifestyle.
- Individuals who are unable to attend medical appointments or follow-up appointments regularly.
- People who are pregnant, planning to become pregnant, or breastfeeding.
Possible side effects
Potential side effects during the first 1-2 weeks of starting the weight-loss pen injection include common symptoms that usually resolve on their own, such as nausea, vomiting, diarrhea, or constipation due to changes in bowel habits. Additionally, there may be abdominal pain, bloating due to excessive gas, foul-smelling belching, and fatigue or weakness in the initial period. Less common and more severe side effects include pancreatitis, hypoglycemia, severe allergic reactions, and problems with the gallbladder and kidneys.
Is the Mounjaro weight-loss pen dangerous if used personally?
Mounjaro weight-loss pens are controlled medications that require dosage adjustments based on individual body composition. Therefore...Performing this yourself without medical supervision is very risky and dangerous. Potential serious side effects include dehydration, pancreatitis, or hypoglycemia.
